Diabetes Articles
What is gestational diabetes?
The term gestational diabetes (GD) refers to diabetes that is diagnosed during pregnancy. Current estimates place between 3% to 25% of all pregnant women to be at risk for gestational diabetes, which has significant consequences for both the fetus and the mother. Many women also develop type 2 diabetes mellitus after GD, which further compounds the need to identify the risks associated with this disease. To date, there has been no causal link established between sugar consumption and the development of GD because sugar consumption plays close to no role in influencing insulin resistance, which is the key mechanism that establishes GD.
Risks of gestational diabetes
As a pregnancy progresses throughout the trimesters, insulin resistance tends to increase in mothers that have GD. High blood sugar levels occur when the insulin-producing pancreas can no longer compensate for the resistance. There are, however, a multitude of known risk factors, and these include being under the age of 25 years; a history of type 2 diabetes mellitus or previous gestational diabetes; race, with those of African heritage particularly at risk; being overweight; having hypertension; polycystic ovarian syndrome; and chronic steroid consumption. These risk factors are used for early detection in the assessment of pregnant mothers who are prone to GD. Tackling the presence of high blood sugar levels is crucial in the early stages of fetal development, so as to ensure the organs develop normally. As mentioned above, being overweight or obese with a Body Mass Index (BMI) above 25 kg/m2 has significant bearing in predisposing pregnant women to suffer from GD.
One reason for the misconception that sugar causes GD may come from the fact that there may be excess carbohydrate intake in individuals with the disease. Excessive consumption of dessert foods, such as cake, cookies, and other confectionaries that tend to be major part of the diets of some obese individuals can lead to the false assumption that sugar and gestational diabetes have a causal link.
—
Disclaimer: Please note that the contents of this community article are strictly for informational purposes and should not be considered as medical advice. This article, and other community articles, are not written or reviewed for medical validity by Canadian Insulin or its staff. All views and opinions expressed by the contributing authors are not endorsed by Canadian Insulin. Always consult a medical professional for medical advice, diagnosis, and treatment.
Victoza Foods to Avoid: Tips for a Healthier Lifestyle
Summary: Understanding Victoza foods to avoid can enhance the medicine’s effectiveness and minimize side effects. Avoid high-sugar, greasy, and processed foods, which can interfere with blood sugar control and increase…
Victoza Dosing Guide: How to Use for Maximum Effectiveness
Summary: Victoza, a GLP-1 receptor agonist, is an effective medication for managing type 2 diabetes and promoting weight loss. Following the correct Victoza dosing schedule ensures optimal results, reduces side…
Victoza vs Ozempic: A Side-by-Side Comparison for Patients
Summary: Victoza vs Ozempic, both are GLP-1 receptor agonists that manage type 2 diabetes and support weight loss. While they share similar benefits, such as blood sugar control, Ozempic offers…
Victoza Weight Loss Journey: Benefits and Side Effects Explained
Summary: Victoza weight loss suppresses appetite, slows gastric emptying, and improves insulin sensitivity. Aside from shedding weight, Victoza contributes to cardiovascular benefits while controlling blood sugar levels. However, potential side…
SGLT2 Inhibitors: A Promising New Approach in Cancer Treatment
Discover how SGLT2 inhibitors, beyond managing diabetes, are emerging as promising anticancer agents by targeting cancer cell metabolism and inhibiting tumor growth.Cancer remains one of the leading causes of death…
Potential Role of SGLT2 Inhibitors in Autism Spectrum Disorders: A New Horizon in Neuropharmacology
Explore the potential of SGLT2 inhibitors, commonly used for diabetes, as a novel treatment for Autism Spectrum Disorders by reducing oxidative stress and neuroinflammation.Autism Spectrum Disorders (ASD) are a group…
Mapping Insulin Accessibility in Major U.S. Cities: Bridging the Gaps
The rise in diabetes cases across urban areas has turned insulin accessibility into a pressing public health issue. While major U.S. cities are often considered hubs of advanced healthcare systems,…
GLP-1 Receptor Agonists: Exploring Their Potential in Opioid Addiction Treatment
Summary GLP-1 receptor agonists (GLP-1RAs) show potential in treating opioid addiction by reducing cravings and relapse in animal models. While some studies indicate promising results, further research in humans is…
Exploring the Potential of GLP-1 Receptor Agonists in Mitigating Amphetamine-Induced Behaviors: A Comprehensive Review
Summary: GLP-1 receptor agonists (GLP-1RAs) show promise in reducing amphetamine-induced behaviors, including hyperactivity and addiction-related preferences. Preclinical studies using Exendin-4 (Ex-4) have demonstrated its ability to decrease dopamine release in…
How to Get a Synjardy Savings Card and Save on Your Prescription
Summary: The Synjardy Savings Card helps eligible patients save on their prescription costs, often reducing co-pays to as low as $10 per month. This guide explains how to apply, use…
Synjardy 12.5 mg/1000 mg: How It Works to Control Blood Sugar
Summary: Synjardy 12.5 mg/1000 mg is a powerful combination medication for managing type 2 diabetes. Blending empagliflozin and metformin targets insulin resistance and blood sugar regulation simultaneously. This comprehensive approach…
What Is Synjardy Used For? Breaking Down Its Role in Treatment
Summary: Synjardy is a powerful combination medication used to manage type 2 diabetes effectively. Combining empagliflozin and metformin helps lower blood sugar levels and lessen the risk of diabetes-related complications.…